Abstract
RWD35 Assessing Pharmacoequity in PARPi Therapy Utilization and Outcomes in Ovarian Cancer Patients: Insights From Real-World Evidence
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have